BACKGROUND: Increased glucose uptake and utilization via aerobic glycolysis are among the most prominent hallmarks of tumor cell metabolism. Accumulating evidence suggests that similar metabolic changes are also triggered in many virus-infected cells. Viral propagation, like highly proliferative tumor cells, increases the demand for energy and macromolecular synthesis, leading to high bioenergetic and biosynthetic requirements. Although significant progress has been made in understanding the metabolic changes induced by viruses, the interaction between host cell metabolism and arenavirus infection remains unclear. Our study sheds light on these processes during lymphocytic choriomeningitis virus (LCMV) infection, a model representative of the Arenaviridae family. METHODS: The impact of LCMV on glucose metabolism in MRC-5 cells was studied using reverse transcription-quantitative PCR and biochemical assays. A focus-forming assay and western blot analysis were used to determine the effects of glucose deficiency and glycolysis inhibition on the production of infectious LCMV particles. RESULTS: Despite changes in the expression of glucose transporters and glycolytic enzymes, LCMV infection did not result in increased glucose uptake or lactate excretion. Accordingly, depriving LCMV-infected cells of extracellular glucose or inhibiting lactate production had no impact on viral propagation. However, treatment with the commonly used glycolytic inhibitor 2-deoxy-D-glucose (2-DG) profoundly reduced the production of infectious LCMV particles. This effect of 2-DG was further shown to be the result of suppressed N-linked glycosylation of the viral glycoprotein. CONCLUSIONS: Although our results showed that the LCMV life cycle is not dependent on glucose supply or utilization, they did confirm the importance of N-glycosylation of LCMV GP-C. 2-DG potently reduces LCMV propagation not by disrupting glycolytic flux but by inhibiting N-linked protein glycosylation. These findings highlight the potential for developing new, targeted antiviral therapies that could be relevant to a wider range of arenaviruses.

Functional Genomics and Proteomics of Plants Central European Institute of Technology and National Centre for Biomolecular Research Masaryk University Brno Czech Republic

Institute of Virology Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Zobrazit více v PubMed

Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi: 10.1126/science.123.3191.309. PubMed DOI

Heiden V, Matthew G, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi: 10.1126/science.1160809. PubMed DOI PMC

Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27(1):441–464. doi: 10.1146/annurev-cellbio-092910-154237. PubMed DOI

Polcicova K, Badurova L, Tomaskova J. Metabolic reprogramming as a feast for virus replication. Acta Virol. 2020;64(2):201–215. doi: 10.4149/av_2020_210. PubMed DOI

Mayer KA, Stöckl J, Zlabinger GJ, Gualdoni GA. Hijacking the supplies: metabolism as a novel facet of virus-host interaction. Front Immunol. 2019;10:1533. doi: 10.3389/fimmu.2019.01533. PubMed DOI PMC

Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479–480:609–618. doi: 10.1016/j.virol.2015.02.038. PubMed DOI PMC

Thaker SK, Ch’ng J, Christofk HR. Viral hijacking of cellular metabolism. BMC Biol. 2019;17(1):59. doi: 10.1186/s12915-019-0678-9. PubMed DOI PMC

Buchmeier MJ, de la Torre JC, Peters CJ. Arenaviridae. In: Fields virology, 6th edn. 2014. p. 1283–303.

Hallam SJ, Koma T, Maruyama J, Paessler S. Review of mammarenavirus biology and replication. Front Microbiol. 2018;9:1751. doi: 10.3389/fmicb.2018.01751. PubMed DOI PMC

Barton LL, Mets MB. congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis. 2001;33:370–374. doi: 10.1086/321897. PubMed DOI

Jamieson DJ, Kourtis AP, Bell M, Rasmussen SA. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol. 2006;194:1532–1536. doi: 10.1016/j.ajog.2005.11.040. PubMed DOI

Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med. 2008;358(10):991–998. doi: 10.1056/NEJMoa073785. PubMed DOI

Parker WB. Metabolism and antiviral activity of ribavirin. Virus Res. 2005;107(2):165–171. doi: 10.1016/j.virusres.2004.11.006. PubMed DOI

Tomaskova J, Oveckova I, Labudova M, Lukacikova L, Laposova K, Kopacek J, et al. Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J Virol. 2011;85(24):13069–13076. doi: 10.1128/JVI.00829-11. PubMed DOI PMC

Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033. doi: 10.1126/science.1160809. PubMed DOI PMC

Navale AM, Paranjape AN. Glucose transporters: physiological and pathological roles. Biophys Rev. 2016;8(1):5–9. doi: 10.1007/s12551-015-0186-2. PubMed DOI PMC

Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2–3):121–138. doi: 10.1016/j.mam.2012.07.001. PubMed DOI PMC

Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202(3):654–662. doi: 10.1002/jcp.20166. PubMed DOI

Delgado T, Carroll PA, Punjabi AS, Margineantu D, Hockenbery DM, Lagunoff M. Induction of the Warburg effect by Kaposi’s sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci. 2010;107(23):10696–10701. doi: 10.1073/pnas.1004882107. PubMed DOI PMC

Gualdoni GA, Mayer KA, Kapsch AM, Kreuzberg K, Puck A, Kienzl P, et al. Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication. Proc Natl Acad Sci. 2018;115(30):E7158–E7165. doi: 10.1073/pnas.1800525115. PubMed DOI PMC

Fontaine KA, Sanchez EL, Camarda R, Lagunoff M. Dengue virus induces and requires glycolysis for optimal replication. J Virol. 2015;89(4):2358–2366. doi: 10.1128/JVI.02309-14. PubMed DOI PMC

Kurtoglu M, Maher JC, Lampidis TJ. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxidants Redox Signal. 2007;9(9):1383–1390. doi: 10.1089/ars.2007.1714. PubMed DOI

Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, et al. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther. 2007;6(11):3049–3058. doi: 10.1158/1535-7163.MCT-07-0310. PubMed DOI

Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, Mesri EA. Activation of the unfolded protein response by 2-deoxy-D-Glucose Inhibits Kaposi’s sarcoma-associated herpesvirus replication and gene expression. Antimicrob Agents Chemother. 2012;56(11):5794–5803. doi: 10.1128/AAC.01126-12. PubMed DOI PMC

Wright KE, Spiro RC, Burns JW, Buchmeier MJ. Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology. 1990;177(1):175–183. doi: 10.1016/0042-6822(90)90471-3. PubMed DOI PMC

Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006;2(12):e132. doi: 10.1371/journal.ppat.0020132. PubMed DOI PMC

Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011;7(7):e1002124. doi: 10.1371/journal.ppat.1002124. PubMed DOI PMC

Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010;6(1):e1000719. doi: 10.1371/journal.ppat.1000719. PubMed DOI PMC

Sanchez EL, Pulliam TH, Dimaio TA, Thalhofer AB, Delgado T, Lagunoff M. Glycolysis, glutaminolysis, and fatty acid synthesis are required for distinct stages of Kaposi’s sarcoma-associated herpesvirus lytic replication. J Virol. 2017;91(10):e02237–e2316. doi: 10.1128/JVI.02237-16. PubMed DOI PMC

Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC–MS/MS analysis. Virology. 2011;415(2):153–159. doi: 10.1016/j.virol.2011.04.007. PubMed DOI PMC

Benej M, Danchenko M, Oveckova I, Cervenak F, Tomaska L, Grossmannova K, et al. Quantitative proteomics reveal peroxiredoxin perturbation upon persistent lymphocytic choriomeningitis virus infection in human cells. Front Microbiol. 2019;10:2438. doi: 10.3389/fmicb.2019.02438. PubMed DOI PMC

Déry MAC, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol. 2005;37:535–540. doi: 10.1016/j.biocel.2004.08.012. PubMed DOI

Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology. 2009;24:97–106. doi: 10.1152/physiol.00045.2008. PubMed DOI

Kavanagh Williamson M, Coombes N, Juszczak F, Athanasopoulos M, Khan M, Eykyn T, et al. Upregulation of glucose uptake and hexokinase activity of primary human CD4+ T cells in response to infection with HIV-1. Viruses. 2018;10(3):114. doi: 10.3390/v10030114. PubMed DOI PMC

Bhatt AN, Kumar A, Rai Y, Kumari N, Vedagiri D, Harshan KH, et al. Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions. Life Sci. 2022;295:120411. doi: 10.1016/j.lfs.2022.120411. PubMed DOI PMC

Iurlaro R, Püschel F, Lucía León-Annicchiarico C, O’connor H, Martin SJ, Palou-Gramón D, et al. Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol Cell Biol. 2017;37(10):e00479–e516. doi: 10.1128/MCB.00479-16. PubMed DOI PMC

Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Liu X, et al. 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol. 2010;67(4):899–910. doi: 10.1007/s00280-010-1391-0. PubMed DOI PMC

Farah IO. Differential modulation of intracellular energetics in A549 and MRC-5 cells. Biomed Sci Instrum. 2007;43:110–115. PubMed

Monchusi B, Ntwasa M. Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: potential use as adjunctive to chemotherapy. PLoS ONE. 2017;12(8):e0182789. doi: 10.1371/journal.pone.0182789. PubMed DOI PMC

Lambert K, Pirt SJ. Growth of human diploid cells (strain MRC-5) in defined medium; replacement of serum by a fraction of serum ultrafiltrate. J Cell Sci. 1979;35:381–392. doi: 10.1242/jcs.35.1.381. PubMed DOI

Datema R, Schwarz RT. Intereference with glycosylation of glycoproteins. Inhibition of formation of lipid-linked oligosaccharides in vivo. Biochem J. 1979;184(1):113–123. doi: 10.1042/bj1840113. PubMed DOI PMC

Kaluza G, Schmidt MFG, Scholtissek C. Effect of 2-deoxy-d-glucose on the multiplication of semliki forest virus and the reversal of the block by mannose. Virology. 1973;54(1):179–189. doi: 10.1016/0042-6822(73)90127-X. PubMed DOI

Knowles RW, Person S. Effects of 2-deoxyglucose, glucosamine, and mannose on cell fusion and the glycoproteins of herpes simplex virus. J Virol. 1976;18(2):644–651. doi: 10.1128/jvi.18.2.644-651.1976. PubMed DOI PMC

Klenk HD, Schwarz RT. Viral glycoprotein metabolism as a target for antiviral substances. Antiviral Res. 1982;2(4):177–190. doi: 10.1016/0166-3542(82)90041-9. PubMed DOI PMC

Leavitt R, Schlesinger S, Kornfeld S. Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses. J Virol. 1977;21(1):375–385. doi: 10.1128/jvi.21.1.375-385.1977. PubMed DOI PMC

Padula PJ, De Martinez Segovia ZM. Replication of Junin virus in the presence of tunicamycin. Intervirology. 1984;22(4):227–231. doi: 10.1159/000149555. PubMed DOI

Wang Y, Li JR, Sun MX, Ni B, Huan C, Huang L, et al. Triggering unfolded protein response by 2-Deoxy-d-glucose inhibits porcine epidemic diarrhea virus propagation. Antiviral Res. 2014;106(1):33–41. doi: 10.1016/j.antiviral.2014.03.007. PubMed DOI PMC

Sun L, Yi L, Zhang C, Liu X, Feng S, Chen W, et al. Glutamine is required for snakehead fish vesiculovirus propagation via replenishing the tricarboxylic acid cycle. J Gen Virol. 2016;97(11):2849–2855. doi: 10.1099/jgv.0.000597. PubMed DOI

Passalacqua KD, Lu J, Goodfellow I, Kolawole AO, Arche JR, Maddox RJ, et al. Glycolysis is an intrinsic factor for optimal replication of a norovirus. MBio. 2019;1(2):e02175–e2218. PubMed PMC

Pasqual G, Burri DJ, Pasquato A, de la Torre JC, Kunz S. Role of the host cell’s unfolded protein response in arenavirus infection. J Virol. 2011;85(4):1662–1670. doi: 10.1128/JVI.01782-10. PubMed DOI PMC

Jheng JR, Ho JY, Horng JT. ER stress, autophagy, and RNA viruses. Front Microbiol. 2014;5:388. doi: 10.3389/fmicb.2014.00388. PubMed DOI PMC

Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, et al. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421. doi: 10.1038/srep08421. PubMed DOI PMC

Peña J, Harris E. Dengue virus modulates the unfolded protein response in a time-dependent manner. J Biol Chem. 2011;286(16):14226–14236. doi: 10.1074/jbc.M111.222703. PubMed DOI PMC

Turpin J, Frumence E, Harrabi W, Haddad JG, El Kalamouni C, Desprès P, et al. Zika virus subversion of chaperone GRP78/BiP expression in A549 cells during UPR activation. Biochimie. 2020;175:99–105. doi: 10.1016/j.biochi.2020.05.011. PubMed DOI

Foufelle F, Fromenty B. Role of endoplasmic reticulum stress in drug-induced toxicity. Pharmacol Res Perspect. 2016;4(1):1–28. doi: 10.1002/prp2.211. PubMed DOI PMC

Laussel C, Léon S. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms. Biochem Pharmacol. 2020;182:114213. doi: 10.1016/j.bcp.2020.114213. PubMed DOI

Xi H, Kurtoglu M, Lampidis TJ. The wonders of 2-deoxy-d-glucose. IUBMB Life. 2014;66(2):110–121. doi: 10.1002/iub.1251. PubMed DOI

Raez LE, Papadopoulos K, Ricart AD, Chiorean EG, Dipaola RS, Stein MN, et al. A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013;71(2):523–530. doi: 10.1007/s00280-012-2045-1. PubMed DOI

Mesri EA, Lampidis TJ. 2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: relevance to its use in India against SARS-CoV-2. IUBMB Life. 2021;73(10):1198–1204. doi: 10.1002/iub.2546. PubMed DOI PMC